PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.
PhenoCycler-Fusion (CODEX)® Technology and Workflow Steps


PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.

Leinco Technologies offers a wide range of second step reagents including secondary antibodies, streptavidin and UltraAvidin™.

Leinco offers high-purity isotype control antibodies for specific applications for in vivo preclinical studies & diagnostic or research assay controls.

In order to provide the most biologically active proteins, many of Leinco Technologies’ proteins are expressed using mammalian host cells,

Leinco Technologies provides in vivo functional grade antibodies with the highest purity standards in the industry: In vivo GOLDTM & In vivo PLATINUMTM.

Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.

ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.

ProSci Incorporated has been selected as the 2022 Bioz Stars Award Winner in the COVID-19 Category.

Does your research require muscle cells? Lifeline® offers smooth muscle cells isolated from different tissues & skeletal muscle satellite cells.

Negative controls aid precision of immune response monitoring. For HLA-A*02:01 alleles, MBLI offers a “Negative Tetramer” in BV421, PE or APC.